Stevia rebaudiana Bertoni and Its Effects in Human Disease: Emphasizing Its Role in Inflammation, Atherosclerosis and Metabolic Syndrome
No hay miniatura disponible
Fecha
2018
Autores
Rojas, Edward
Bermúdez, Valmore
Motlaghzadeh, Yasaman
Mathew, Justin
Fidilio, Enzamaria
Faria, Judith
Rojas, Joselyn
Cabrera de Bravo, Mayela
Contreras, Julio
Mantilla, Linda Pamela
Título de la revista
ISSN de la revista
Título del volumen
Editor
Springer
Resumen
Purpose of Review. Stevia rebaudiana Bertoni is a perennial shrub with zero calorie content that has been increasing in popularity for its potential use as an adjuvant in the treatment of obesity. The level of evidence supporting general benefits to human health is insufficient. We conducted a review of the literature summarizing the current knowledge and role in human disease.
Recent Findings. Despite stevia’s minimal systemic absorption, studies have been promising regarding its potential benefits against inflammation, carcinogenesis, atherosclerosis glucose control, and hypertension. On the other hand, the growing popularity of artificial sweeteners does not correlate with improved trends in obesity. An increased intake of artificial non-caloric sweeteners may not be associated with decreased intake of traditional sugar-sweetened beverages and foods. The effects of Stevia on weight change have been linked to bacteria in the intestinal microbiome, mainly by affecting Clostridium and Bacteroides sp. populations. A growing body of evidence indicates that Stevia rebaudiana Bertoni is protective against malignant conversion by inhibition of DNA replication in human cancer cell growth in vitro.
Summary. Consumption of Stevia has demonstrated to be generally safe in most reports. Further clinical studies are warranted to determine if regular consumption brings sustained benefits for human health.
Descripción
Palabras clave
Stevia rebaudiana Bertoni, Obesity, Type 2 diabetes, Hypertension